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Abstract 16 
The final decision on cell fate, survival versus cell death, relies on complex 17 
and tightly regulated checkpoint mechanisms. The caspase-3 protease is a 18 
predominant player in the induction of apoptosis. However, this protease 19 
is more than a blind killer. It can gauge the degree of cellular stress and 20 
damage by differential processing of p120 RasGAP to generate the 21 
appropriate cellular response (survival or cell demise). Partial cleavage of 22 
RasGAP by caspase-3 initiates the anti-apoptotic Akt pathway. In contrast, 23 
full cleavage of RasGAP abrogates this survival response, hence favoring 24 
cell death. Therefore, rather than relying on separate sensors, cells can 25 
modulate a given set of proteins to generate, depending on the intensity of 26 
the input signals, opposite outcomes (survival vs. death). 27 
  28 
2  
Introduction 29 Proper functioning of cells requires that they maintain their biochemical 30 parameters within rather narrow limits. This process, called homeostasis, is vital 31 for cells and they spend a considerable energy to maintain it. For example, the 32 appropriate gradient of sodium and potassium ion concentrations between the 33 inside and the outside of brain cells via the action of the sodium/potassium 34 ATPase pump consumes close to half of the ATP used at the basal state [1]. If the 35 extracellular conditions are changing too much or if the cellular biochemistry is 36 exceedingly altered, such as following viral infection [2,3] or oncogene 37 expression [4], than homeostasis maintenance is compromised. This 38 perturbation is sensed by cells as cellular stress. Situations and conditions that 39 can generate cellular stress are extremely diverse. They include environmental 40 pollutants, metabolic stress induced by toxic lipids in obese individuals, UV-41 mediated stress generated by prolonged exposure of the epidermis to sun 42 exposure, endoplasmic reticulum stress caused by sustained chronic increase in 43 insulin production by pancreatic beta cells in type 2 diabetes patients, chemical 44 or ionizing stress that cancer patients experience when treated with chemo- or 45 radiotherapy, or physicochemical stress provoked by heat or cold exposure. 46 When encountering a stress condition, cells have two options, either to cope with 47 it, which requires an adaptive response, or to give up and die, which involves the 48 initiation of an active and programmed cell death process. Cells are in fact well 49 equipped to sense the extent of stress and this allows them to decide whether 50 they should try to restore homeostasis or whether they should commit suicide 51 because stress is evaluated as too extensive and potentially deleterious. Various 52 switch mechanisms can be used by cells to evaluate stress and insults to either 53 3  
promote cell survival or apoptosis. We will focus here on a newly described 54 physiologic stress-sensing cellular system based on the differential cleavage of a 55 specific caspase-3 substrate. 56  57 
Caspase-3, from reaper to friendly protease 58 At the end of the nineties, a consensus emerged that apoptosis (Box1) was 59 carried on by the executioner members of the caspase family (Box1) (caspase-3, 60 -6, and -7) [5-8]. Caspase-3 has been considered as the central executioner 61 protease due to its high catalytic turnover and greediness to cleave substrates 62 [9]. Gene targeting in mice has revealed a certain level of redundancy in the 63 function of executioner caspases in apoptosis induction [10], and more 64 importantly that these executioner caspases fulfill other non-apoptotic functions 65 as well [11]. 66 Historically however, non-apoptotic functions of pro-apoptotic caspases were 67 first discovered for caspase-8, an initiator caspase. It was shown in 1998 that 68 mice lacking caspase-8 were embryonic lethal [12]. This lethality was later 69 shown to result from degeneration of the vasculature of the yolk sac [13]. This 70 suggested that caspase-8 is required for the proper development and/or the 71 maintenance of vascular structures in the early embryo, which is most certainly 72 distinct from its ability to mediate apoptosis via the extrinsic cell death pathway.  73 Also in 1998, it was shown that cell expressing CrmA, a caspase-8 inhibitor, were 74 paradoxically sensitized to necrotic cell death [14], suggesting that caspase-8 75 could also promote cell survival [15]. Non-apoptotic functions were then 76 progressively reported for other caspases and a series of reviews have been 77 describing these in the past decade [11,16-21]. Caspase-3 in particular appears 78 4  
to regulate the differentiation of skeletal muscle cells, osteoblasts, lens epithelial 79 cells, neural stem cells, and several hematopoietic lineages (T and B 80 lymphocytes, erythrocytes, macrophages, platelets). Caspase-3 has also been 81 reported to participate in stem cell maintenance, inhibition of B-cell 82 proliferation, dendritic cell maturation, and proliferation of brain cells and 83 keratinocytes [22-25]. 84 The levels of activated caspase-3 that stimulate the non-apoptotic biological 85 responses should obviously be lower than during apoptosis otherwise this cell 86 death process would not be avoided. Numerous substrates of caspase-3 have 87 been determined [9,26-28]. However their role in apoptosis has only been 88 explored in a few cases. Additionally, the impact of caspase-mediated cleavage 89 for the vast majority of substrates has not been explored by studying the 90 phenotype of cells or mice in which the wild-type substrate is replaced with a 91 non-cleavable knock-in form. 92 Different executioner caspases can target the same substrates while a given 93 caspase can cleave some substrates better than others [9,29]. In particular, 94 caspase-3 appears to cleave most substrates more efficiently than other caspases 95 [29]. It is conceivable that the high Km value of caspase-3 for some of its 96 substrates is related to its non-apoptotic functions while apoptosis may imply 97 the less effective substrates. In other words, low activation levels of caspase-3, 98 leading to restricted cleavage of high affinity substrates, would allow survival 99 while higher levels of caspase-3 activation would result in the cleavage of a much 100 wider spectrum of substrates, including low affinity ones, ultimately leading to 101 the induction of apoptosis. 102 
5  
In addition to the possible differential affinity of caspase-3 toward the anti- and 103 pro apoptotic substrates, there are other mechanisms that can keep caspase-3 104 activation levels in check during stressful situations. One possibility is that cells 105 have a built-in system that prevents amplification of caspase-3 activation. The 106 best-known family of proteins that can negatively control executioner caspases 107 is the inhibitor of apoptosis (IAPs) protein family. IAPs are characterized by one 108 to three baculovirus IAP repeat (BIR) zinc-binding domain, which, at least for 109 some IAP family members, is required for their ability to bind caspases [30]. 110 However, contrary to initially speculated, X-linked IAP (XIAP) is the only IAP that 111 can function as a direct inhibitor of caspase-3, -7 and -9 [31,32]. Cellular IAP1 112 and 2 (cIAP1/2) instead promote cell survival by functioning as E3 ubiquitin 113 ligases that promote the degradation of caspase-3 and -7 [33] and positively 114 regulate activation of the canonical NF-kB pathway [34-36]. In addition, cIAP1/2 115 function as regulators of survival signaling in cancer cells by preventing RIPK1 116 from becoming a pro-death stress sensing molecule [37]. Hence, IAP family 117 members allow cells to cope with stress to a certain limit if they are expressed at 118 sufficiently high levels either by activating NF-kB, preventing RIPK1 from 119 becoming a pro-death molecule or by keeping caspase-3 activity in check. 120 Another possibility that can explain why activation of caspase-3 does not lead to 121 apoptosis in all cases is that caspase-3 itself, when activated at low levels, turns 122 on an anti-apoptotic response that acts as a negative feedback loop preventing 123 further caspase-3 activation (i.e. an amplification of caspase-3 activity). A recent 124 study [38] provides genetic evidence for this second possibility. In the C57BL/6 125 background, mice lacking caspase-3 are viable and fertile [39]. The vast majority 126 of development programs occur normally in these mice. They do however 127 6  
display abnormal inner ear development [40]. It is not known whether this 128 defect results from a defect in apoptosis or from alterations of other functions 129 controlled by caspase-3. Apoptosis in these mice can proceed normally or be 130 inhibited, depending on which tissues and organs are investigated. For example, 131 female germ cell apoptosis is not affected by the lack of caspase-3 while 132 granulosa cell apoptosis is not taking place during follicular atresia when this 133 caspase is missing [41]. Caspase-3 knock-out mice are unable or strongly 134 impaired in activating the anti-apoptotic Akt kinase (box 2) in response to a 135 variety of stresses such as UV-B exposure of the skin, doxorubicin-mediated 136 cardiac damage, and experimentally-induced colitis, an inflammation of the large 137 intestine. Akt activation is also compromised in wild-type mice injected with the 138 Q-VD-OPh caspase inhibitor suggesting that the activity of caspase-3, and not a 139 potential adaptor function of the protein, is required for its capacity to activate 140 Akt. As detailed below, the defect in Akt activation in mice lacking caspase-3 is 141 accompanied by increased cell death responses. Caspase-3 therefore appears to 142 stimulate survival responses in some situations. 143 As caspase-3 is a main executioner caspase, its absence generally compromises 144 or abrogates apoptosis induction by various stress inducing conditions. For 145 example, pancreatic beta cells lacking caspase-3 are fully resistant against 146 streptozotocin-induced death [42]. Even though absence of caspase-3 generally 147 reduces the apoptotic response, this does not mean necessarily that the death 148 response is lowered. For example, UV-B-induced apoptosis is decreased in the 149 epidermis of caspase-3 KO mice but the overall death response is not, as in the 150 absence of apoptosis induction cell death proceeds in caspase-independent cell 151 death with necrotic morphology [38]. 152 7  
In some cases, caspase-7 can compensate, at least partially by enhanced 153 expression levels in C57Bl6 strains for the lack of caspase-3 and allow apoptosis 154 to proceed [10]. Doxorubicin is an efficient anti-cancer drug that is currently 155 used against various tumors. However, this drug also induces serious cardiac 156 side effects. Cardiomyocytes are indeed rather sensitive to doxorubicin and 157 readily undergo apoptosis when exposed to the drug. Unexpectedly, caspase-3 158 knock-out mice experience even more cardiomyocyte apoptosis than wild-type 159 mice when treated with doxorubicin, leading to increased mortality [38]. This 160 suggests that the apoptotic role of caspase-3 is redundant while its prosurvival 161 role in stressed tissues and organs is not. 162  163 
Cellular sensor of caspase-3 activity  164 There is only a handful proteins including p120 RasGAP[43], p27kip1 [44], Lyn 165 [45], Synphilin-1 [46], nucleophosmin [47], Rb [48], and the Drosophila IMD 166 protein [49] that may activate survival pathways once cleaved by caspases. The 167 first of these, RasGAP, is of particular interest in the present context because the 168 N-terminal moiety generated by cleavage of RasGAP at position 455 by caspase-3 169 activates Akt and protects cells in vitro [50,51]. In cells, RasGAP does not seem to 170 be cleaved by caspases other than caspase-3 [51]. RasGAP bears another 171 caspase-3 cleavage site at position 157 that is made accessible only following the 172 first cleavage event or that is much less efficiently recognized by caspases [43]. 173 Consequently, the second site is not used when caspase-3 is mildly activated [52] 174 (Figure 1, upper left panel). However, after an apoptotic insult, concentrations of 175 activated caspase-3 further increases, reaching a threshold allowing the N-176 terminal fragment of RasGAP to be cleaved at position 157, abrogating Akt 177 8  
activation. The second RasGAP cleavage thus favors death [52] (Figure 1, upper 178 right panel). RasGAP is the only caspase-3 substrate that shows this differential 179 cleavage-mediated control of two opposite outcomes (survival vs apoptosis). 180 Interestingly, RasGAP has no obvious anti-apoptotic activities as a full-length 181 protein [53]. It only acquires cell protective functions when cleaved at position 182 455. The physiological role of caspase-3-mediated cleavage of RasGAP has 183 recently been assessed using a knock-in mouse strain homozygous for a 184 mutation in RasGAP at position 455 that prevents its cleavage by caspase-3. The 185 RasGAP knock-in mice phenocopied the caspase-3 knock-out stress-induced Akt 186 activation defect in response to various patho-physiological stresses (Figure 1, 187 lower panels). The knock-in mice also experienced increased tissue damage and 188 organ dysfunction in response to these insults in comparison to wild-type mice 189 [38]. These results provide genetic evidence for the importance of caspase-3-190 mediated p120 RasGAP cleavage as a defense mechanism to protect organisms 191 against damage induced by diverse pathological conditions.  192 It can therefore be proposed that caspase-3 itself activates the anti-apoptotic Akt 193 kinase following certain types of stresses (e.g. starvation, DNA damage)[51] and 194 this seemingly operates via the efficient cleavage of only one of its substrates, the 195 ubiquitous p120 RasGAP protein. The model drawn for these studies is that 196 RasGAP bears two cleavage sites with differential sensitivities for caspase-3 197 proteolytic activity. RasGAP acts as a “sensor like” protein that reflects the levels 198 of caspase-3 activation, which correlates with the extent of cellular stress. This 199 differential cleavage aids determining the fate of stressed cells: activation of a 200 protective Akt-dependent pathway following the first cleavage of RasGAP or 201 
9  
inactivation of this protective pathway following the second cleavage of RasGAP 202 (Figure 1, upper panels). 203  204 
Perspectives: one set of signaling proteins, different outcomes 205 There are other comparable decision-making systems assessing the magnitude 206 of cellular stress, where within a given signaling pathway, differential regulatory 207 events dictate distinct cell signaling events. These “sensor-like” responses 208 include the unfolded protein response (UPR) in the endoplasmic reticulum and 209 the activation of p53 transcription factor pathway by DNA damage. What 210 determines the cellular outcome once a given switch is triggered relies on the 211 duration and the extent of the stress that allows or not the accumulation of pro-212 apoptotic genes, either as a consequence of differential stability of the anti- and 213 pro-apoptotic proteins or as a result of post-translational modifications of the 214 switch components (Figure 2). For instance, the goal of the UPR initially is to try 215 restoring the folding capacity of the ER while diminishing protein load in order 216 to reestablish ER homeostasis [54-56]. Only a strong and sustained ER stress 217 allows for the accumulation of pro-apoptotic labile proteins such as the 218 transcription factor CHOP [56,57]. Similarly, distinct post-translational 219 modifications (e.g. acetylation on lysine 150 or phosphorylation of serine 46) 220 generated by various degrees of DNA damage, determines whether p53 221 preferentially stimulates a repair pathway versus a cell death response [58-60]. 222 From these examples one could propose a general paradigm were cellular stress 223 is sensed by molecules and pathways that stimulate either cell survival or 224 apoptosis based on the extent of their stimulation (as in the case of the UPR) or 225 as a result of stress-mediated differential post-translational modifications (e.g. 226 10  
cleavage of RasGAP, acetylation/phosphorylation of p53). Hence, cells may use 227 the same set of sensor proteins to fine-tune an appropriate cellular response 228 either resulting in cell survival or cellular demise, rather than relying on 229 separate sensors for either response.  230 
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Figure legends 231 
 232 
Figure 1. RasGAP cleavage, a sensor of caspase-3-activity controlling the 233 
survival and the death of cells. 234 RasGAP bears two cleavage sites with different sensitivities towards caspase-3 235 activity. Site 1 at position 455 is used at low levels of caspase-3 activity, while 236 site 2, at position 157, is only recognized at high levels of caspase-3 activity. 237 
Upper left panel. In situations of mild stress, caspase-3 is activated to low levels 238 and this leads to the partial cleavage of RasGAP into fragment C and fragment N. 239 The latter activates an Akt-mediated anti-apoptotic response that inhibits 240 further amplification of caspase-3 activity. Upper right panel. When cells are 241 facing higher stress, caspase-3 is more strongly activated resulting in further 242 cleavage of fragment N and abrogation of Akt activation. This favors cell death. 243 
Lower panels. When cleavage of RasGAP cannot occur as a result of a mutation 244 at its first caspase-3 cleavage site, the prosurvival kinase Akt is not stimulated. In 245 this condition, the feedback loop that prevents an initially mild caspase-3 activity 246 is not activated and this results in an amplification of caspase-3 activity. 247 Consequently, mild stresses generate elevated caspase-3 activation comparable 248 to when cells experience stronger stresses. This eventually leads to cell death. 249  250 
Figure 2. Examples of mechanisms allowing single stress sensors to 251 
activate survival or death responses 252 A given protein or set of proteins can determine the fate of a cell (survival vs 253 death). This can result as a consequence of a differential cleavage of a protease 254 substrate (e.g. cleavage of RasGAP by caspase-3) (upper panel), the 255 12  
accumulation above a certain threshold of a labile transcription factor (e.g CHOP 256 translation following ER stress) (middle panel), or differential post-257 translational modifications (e.g. as occurring on p53 in response to varying 258 degrees of DNA damage) (lower panel). 259 
  260 
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Box 1. Apoptosis and caspases 261 Apoptosis (apo=for, ptosis=falling) is a type of cell death that was formally 262 described by Kerr, Wyllie and Currie in the early 1970s [61]. Apoptosis 263 participates in the control of tissue size and shape during development. It is 264 involved in the elimination of cells that may represent a threat to the organism 265 such as pre-malignant cells and activated immune T cells. Apoptosis is 266 characterized by a series of organized and finely regulated biochemical and 267 cellular modifications that process the dying cells for efficient elimination by 268 phagocytosis by neighboring cells or macrophages. This insures that no 269 cytoplasmic compounds leak from the cells that would otherwise generate an 270 inflammatory response [62]. The hallmarks of apoptosis include cell shrinkage, 271 membrane blebbing, nuclear and cytoplasmic condensation, DNA fragmentation, 272 cytoskeleton proteolysis and breakup of organelles. Cellular components are 273 sorted into a number of vesicles known as apoptotic bodies. Only a few of these 274 events are diagnostic for apoptosis (DNA cleavage, formation of apoptotic 275 bodies). Intact apoptotic cells display “eat-me” flags on their surface such as 276 phosphatidylserine that tag them as targets for phagocytosis. Phosphatidylserine 277 is usually confined to the inner side of the plasma membrane but becomes 278 exposed on the surface of apoptotic cells [63,64]. 279 The cellular and biochemical features of apoptosis are triggered by members of 280 the caspase family of proteases. Caspases are a family of cysteine aspartic acid 281 proteases present in healthy cells as inactive precursor enzymes (zymogens). All 282 caspases have a similar domain structure (pro-polypeptide, large and small 283 subunits) [65]. Domains within the pro-polypeptide, such as caspase recruitment 284 domain (CARD) and death effector domain (DED), by homophylic interactions, 285 14  
can recruit caspases to activation platforms. Not all caspases are implicated in 286 apoptosis but those that are can be divided into initiator (caspase-2, -8, and -9) 287 or executor caspases (caspase-3, -6, and -7). The former auto-activate when 288 brought together by receptors belonging to the death receptor family (e.g. Fas). 289 The latter are activated by the former by proteolysis and execute the proteolysis 290 events that are seen during the demolition phase of apoptosis [62,66]. 291 Executioner caspases cleave hundreds of substrates during the process of 292 apoptosis but only for a minority of these is the physiological function of their 293 cleavage understood. These include ICAD, the inhibitor of CAD, the DNAse that 294 cleaves the DNA between nucleosomes. Caspase-mediated cleavage of ICAD leads 295 to CAD activation, generating ~180 base pair multimeric DNA fragments, the 296 diagnostic laddering in apoptotic cells. 297  298 
Box 2. The generally pro-survival Akt pathway 299 Akt is a serine/threonine kinase involved in the regulation of cell survival, 300 proliferation, and metabolism and is activated by phosphorylation. Three 301 isoforms exist (1, 2, and 3) that all contain an N-terminal pleckstrin homology 302 (PH) domain, a central kinase domain containing a phosphorylation site within 303 the activation-loop (threonine 308 in human Akt1), and a conserved regulatory 304 serine phosphorylation site in a hydrophobic motif near the C terminus (position 305 473 in human Akt1). The interaction of the Akt PH domain with 3’-306 phosphoinositides causes Akt translocation to the plasma membrane, inducing 307 conformational changes that allow Akt to expose its phosphorylation sites [67]. 308 Phosphoinositide-dependent kinase-1 (PDK-1) is also recruited to the plasma 309 membrane after PIP3 generation. PDK-1 is the kinase that phosphorylates Akt on 310 15  
threonine 308, which stabilizes the activation loop in an active conformation. 311 Serine 473 is then phosphorylated by the PDK2 kinase activity which is 312 predominantly carried out by mammalian target of rapamycin (mTOR) complex 313 2 (mTORC2) or DNA-PK. Phosphorylation of threonine 308 is a prerequisite for 314 kinase activation. Phosphorylation of serine 473 appears to further increase Akt 315 kinase activity. Recent evidence suggests that this phosphorylation event also 316 controls the target specificity of the kinase [67]. 317 Among the Akt substrates that have been identified in mammalian cells, many 318 are regulators of apoptosis or cell growth [67]. The Akt substrates are 319 phosphorylated within the same basic motif RXRXXS/T. The anti-apoptotic 320 response induced by Akt involves NF-κB- or CREB-mediated up-regulation of 321 anti-apoptotic proteins such as c-IAP1/2, Mcl-1 and Bcl-2, or the direct 322 phosphorylation and inhibition of pro-apoptotic proteins such as Bad and 323 caspase-9. It is worth noting however that the Akt phosphorylation site in 324 caspase-9 is not conserved in mammals [68]. Akt also inhibits members of the 325 Forkhead family of transcription factors (FOXO transcription factors). This 326 prevents the expression of pro-apoptotic genes such as Fas ligand. Additionally, 327 murine double minute 2 (MDM2), an E3 ubiquitin ligase targeting p53 for 328 degradation, is stabilized by Akt-mediated phosphorylation. This will therefore 329 diminish p53-induced pro-apoptotic signaling in cells. Therefore, Akt promotes 330 survival in most cells either through direct phosphorylation of targets, or 331 through the induction of anti-apoptotic genes [67]. There are some cell types 332 however in which Akt activation can lead to death. In pancreatic beta cells for 333 example, Akt activation leads to NF-κB-dependent apoptosis [69]. 334   335 16  
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